BACKGROUND: Resistant starch sources, which are only partially digested in the small intestine, can be used to increase colonic availability of short-chain fatty acids. OBJECTIVE: To study the characteristics of the fermentation of resistant starch, the digestion of resistant starch in the small intestine has to be quantified. We compared the metabolic fates of highly digestible cornstarch (DCS), Hylon VII (type 2 resistant starch), and Novelose 330 (type 3 resistant starch), which are of corn origin and, therefore, naturally enriched in (13)C. DESIGN: After administration of 40 g starch or glucose to 7 healthy volunteers, glucose and exogenous glucose concentrations in serum and (13)CO(2) excretion in breath were analyzed for 6 h. (13)C abundance in carbon dioxide was analyzed by isotope ratio mass spectrometry (IRMS) and (13)C abundance in glucose by gas chromatography-combustion IRMS. RESULTS: By comparing the area under the curve (2 h) of exogenous glucose concentration in serum ((13)C glycemic index) after intake of starch or glucose, (13)C glycemic indexes for DCS, Hylon VII, and Novelose 330 were calculated to be 82 +/- 23%, 44 +/- 16%, and 43 +/- 15%, respectively. Comparison of 6-h cumulative percentage dose recovery in breath showed that 119 +/- 28% of DCS, 55 +/- 23% of Hylon VII, and 50 +/- 26% of Novelose 330 was digested in the small intestine. CONCLUSION: The exogenous glucose response in serum and the (13)CO(2) excretion in breath can be used to estimate small intestinal digestion of resistant starch, which amounts to approximately 50%.
BACKGROUND: Resistant starch sources, which are only partially digested in the small intestine, can be used to increase colonic availability of short-chain fatty acids. OBJECTIVE: To study the characteristics of the fermentation of resistant starch, the digestion of resistant starch in the small intestine has to be quantified. We compared the metabolic fates of highly digestible cornstarch (DCS), Hylon VII (type 2 resistant starch), and Novelose 330 (type 3 resistant starch), which are of corn origin and, therefore, naturally enriched in (13)C. DESIGN: After administration of 40 g starch or glucoseto 7 healthy volunteers, glucose and exogenous glucose concentrations in serum and (13)CO(2) excretion in breath were analyzed for 6 h. (13)C abundance in carbon dioxide was analyzed by isotope ratio mass spectrometry (IRMS) and (13)C abundance in glucose by gas chromatography-combustion IRMS. RESULTS: By comparing the area under the curve (2 h) of exogenous glucose concentration in serum ((13)C glycemic index) after intake of starch or glucose, (13)C glycemic indexes for DCS, Hylon VII, and Novelose 330 were calculated to be 82 +/- 23%, 44 +/- 16%, and 43 +/- 15%, respectively. Comparison of 6-h cumulative percentage dose recovery in breath showed that 119 +/- 28% of DCS, 55 +/- 23% of Hylon VII, and 50 +/- 26% of Novelose 330 was digested in the small intestine. CONCLUSION: The exogenous glucose response in serum and the (13)CO(2) excretion in breath can be used to estimate small intestinal digestion of resistant starch, which amounts to approximately 50%.
Authors: R Crittenden; A Laitila; P Forssell; J Mättö; M Saarela; T Mattila-Sandholm; P Myllärinen Journal: Appl Environ Microbiol Date: 2001-08 Impact factor: 4.792
Authors: Darrell W Cockburn; Nicole I Orlovsky; Matthew H Foley; Kurt J Kwiatkowski; Constance M Bahr; Mallory Maynard; Borries Demeler; Nicole M Koropatkin Journal: Mol Microbiol Date: 2014-12-19 Impact factor: 3.501
Authors: Marion G Priebe; Renate E Wachters-Hagedoorn; Janneke A J Heimweg; Alexandra Small; Tom Preston; Henk Elzinga; Frans Stellaard; Roel J Vonk Journal: Eur J Nutr Date: 2008-10-13 Impact factor: 5.614
Authors: Diane F Birt; Terri Boylston; Suzanne Hendrich; Jay-Lin Jane; James Hollis; Li Li; John McClelland; Samuel Moore; Gregory J Phillips; Matthew Rowling; Kevin Schalinske; M Paul Scott; Elizabeth M Whitley Journal: Adv Nutr Date: 2013-11-06 Impact factor: 8.701
Authors: Roos Molenaar; Joost J G C van den Borne; Ewoud Hazejager; Niels B Kristensen; Marcel J W Heetkamp; Ron Meijerhof; Bas Kemp; Henry van den Brand Journal: PLoS One Date: 2013-04-01 Impact factor: 3.240
Authors: Elizabeth A Cameron; Kurt J Kwiatkowski; Byung-Hoo Lee; Bruce R Hamaker; Nicole M Koropatkin; Eric C Martens Journal: mBio Date: 2014-09-09 Impact factor: 7.867